Investor Relations

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them.


News Release

 View printer-friendly version

Charles River Laboratories Schedules Fourth-Quarter and Full-Year 2005 Earnings Release and Conference Call

WILMINGTON, Mass.--(BUSINESS WIRE)--Jan. 9, 2006--Charles River Laboratories International, Inc. (NYSE:CRL) will release fourth-quarter and full-year 2005 financial results on Wednesday, February 8, 2006, after the market closes. A conference call has been scheduled to discuss the results on Thursday, February 9, 2006, at 8:30 a.m. E.T.

Investors will have the opportunity to listen to a live webcast of the conference call through the Investor Relations section of the Company's website at A replay will be accessible through the website approximately two hours following the conference call and will remain available through Thursday, February 16, 2006.

CONTACT: Charles River Laboratories International, Inc.
Susan E. Hardy, 781-262-7616
Corporate Vice President, Investor Relations

SOURCE: Charles River Laboratories International, Inc.

Featured Report

2019 Annual Report (PDF)